For patients with chronic unexplained dyspnea seen in the outpatient setting, the optimal thresholds of plasma NT-proBNP currently used to diagnosis heart failure with preserved ejection fraction ...

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...

The lifetime risk of developing heart failure with reduced ejection fraction (HFrEF) is greater in men, while women are at greater risk of developing HF with preserved EF (HFpEF), according to 25-year ...

Obesity is quite common in patients suffering from heart failure with preserved ejection fraction (HFpEF). 1 Semaglutide is a glucagon-like peptide-1 receptor agonist that has been shown to cause ...

Johns Hopkins’ Center for Heart Failure with Preserved Ejection Fraction (HFpEF) provides specialized care for patients diagnosed with this form of heart failure through education, research and a ...

The objective of this proposal is to determine the effect of resistance exercise training on locomotor muscle function, exercise capacity, exertional symptoms, and quality of life in HF patients with ...

Background Before the emergence of HFpEF, there is an insidious phase of progressive myocardial fibrosis, arterial stiffness, and rising left ventricular end-diastolic pressures (LVEDP) driven by ...

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Diastolic Heart Failure (HFpEF). According to GlobalData, Phase III drugs for Diastolic Heart Failure (HFpEF) ...

The analysis revealed that RA patients exhibited a higher overall rate of heart failure, driven primarily by heart failure with preserved ejection fraction (HFpEF). The findings emphasize the impact ...